France· FR:68603720
ATORVASTATINE ZYDUS 40 mg, comprimé pelliculé
A medicinal product containing atorvastatine calcique trihydratée, registered in France by ZYDUS FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ATORVASTATINE CALCIQUE TRIHYDRATÉE
- Manufacturer
- ZYDUS FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930145388plaquette(s) formée(s) à froid OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)EUR 3.18
- cip133400930145418plaquette(s) formée(s) à froid OPA : polyamide orienté aluminium PVC-Aluminium de 90 comprimé(s)EUR 9.04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Atorvastatine calcique trihydratée in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAMEDOMedochemie Bohemia, spol. s r.o., Praha
- United Statesatorvastatin calciumLepu Pharmaceutical Technology Co., Ltd.
- SpainATORIS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKrka D.D. Novo Mesto
- PolandApo-AtorvaAurovitas Pharma Polska Sp. z o.o.
- BelgiumAtorasat 40 mgSandoz
- ItalyARKASLANOVA FARMACEUTICI S.R.L.
- SwitzerlandAtorva axapharm
- FinlandAtorabRanbaxy (UK) Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Atorvacor, Atorvadivid
- Belgium · Atorstatin, Atorstatin Eg
- Bulgaria · Atorvistat К, Аванор
- Cyprus · Abator, Amicor
- Czechia · Amedo, Atoris
- Germany · Ator, Atoris
- Denmark · Atorvastatin ”hexal”, Atorvastatin "sandoz"
- Estonia · Astator, Atoris
- Spain · Atoris, Atorvastatina Abex
- Finland · Atorbir, Atorvastatin
- United Kingdom (Northern Ireland) · Atorvastatin, Atorvastatin Accord
- Greece · Altoram, Antorcin
- Croatia · Artas, Atoris
- Hungary · Astator, Atoris
- Ireland · Atorvas, Atorvastatin Accord
- Iceland · Atacor, Atorvastatin Krka
- Italy · Arkas, Atoris
- Lithuania · Astator, Atoris
- Luxembourg · Atorstatin, Atorvastatin Micro Labs
- Latvia · Astator, Atoris
- Malta · Atorvastatin Galenicum Health, Atorvastatin Tad
- Netherlands · Atorvastatin Aurobindo, Atorvastatin Mylan
- Norway · Atorvastatin Accord, Atorvastatin Hexal
- Poland · Apo-Atorva, Atoris
- Portugal · Atined, Atorvastatina Alter Genéricos
- Romania · Ascord, Atoris
- Sweden · Atorbir, Atorvastatin 1a Farma
- Slovenia · Atoris, Sortis
- Slovakia · Atoridor, Atoris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f51c3629-eac7-498c-a47d-05aefb743358 GET /v1/drugs/f51c3629-eac7-498c-a47d-05aefb743358?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68603720",
"date_amm": "2018-05-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ATORVASTATINE CALCIQUE TRIHYDRATÉE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about atorvastatine calcique trihydratée.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.